about
Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary AneurysmsInfluence of diabetes mellitus on heart failure risk and outcomeA common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions.Effect of aspirin in addition to oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation.Proteomic analysis in cardiovascular diseases.Profile of macrophages in human abdominal aortic aneurysms: a transcriptomic, proteomic, and antibody protein array study.Role of proinflammatory CD68(+) mannose receptor(-) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humans.Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosisMultimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failureAdventitial Tertiary Lymphoid Organs as Potential Source of MicroRNA Biomarkers for Abdominal Aortic AneurysmDiuretic versus placebo in normotensive acute pulmonary embolism with right ventricular enlargement and injury: a double-blind randomised placebo controlled study. Protocol of the DiPER study.Cardiogenic shock management: Still a challenge and a need for large-registry data.Practice Patterns for Outpatients With Stable Coronary Artery Disease: A Case Vignette-based Survey Among French CardiologistsImaging and modern assessment of the right ventricle.Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group.A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction.Patient education after acute myocardial infarction: cardiologists should adapt their message--French registry of acute ST-elevation or non-ST-elevation myocardial infarction 2010 registry.Copeptin in acute coronary syndromes and heart failure management: State of the art and future directions.Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patients.Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study).Clopidogrel Use as Single Antiplatelet Therapy in Outpatients with Stable Coronary Artery Disease: Prevalence, Correlates and Association with Prognosis (from the CORONOR Study).Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis.Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue: A Clinicopathologic Study of 92 Patients With Amyloid-containing Minor Salivary Gland Biopsies.Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancer.Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probabilityLate recovery in left ventricular systolic function after discharge of patients with a first anterior myocardial infarction.Indication for bromocriptine in peripartum cardiomyopathy.Prognostic impact of ß-blocker use in patients with stable coronary artery disease.Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: Results of a European collaboration assembling more than 2000 patients.Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator.Secondary medical prevention and clinical outcome in coronary artery disease patients with a history of non-coronary vascular intervention: A report from the CORONOR investigators.Incidence, determinants and consequences of left atrial remodelling after a first anterior myocardial infarction.[Endothelin-1 receptor antagonists in heart failure]Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.Right ventricular systolic function in organic mitral regurgitation: impact of biventricular impairment.Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.Pulmonary hypertension associated with benfluorex exposure.The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure.
P50
Q24800120-F79FF2A1-E0F1-4335-83B6-9A0F6D39EEC5Q24800363-61B08150-4434-4CA4-862F-28996A49D59DQ24817217-690FCAD9-0942-4B95-9C1C-A821253A9D93Q30390016-764E47D8-A0C7-429D-ABDF-1BD28A63BD28Q33321675-F6F961A6-9609-4C5D-B8CA-EFE679DDE890Q34118177-412B5180-C035-4670-AF98-77B2D17186D2Q34513260-F744C70E-A51E-4F13-A46D-948881D4F2F9Q35035897-3C2D5A2C-4127-486B-9D4B-1A8B0AE91EB5Q35532994-7040416C-BE0E-450E-A660-5FECC126A614Q35636731-AE2C494B-AB63-46BE-B52B-B483A183D8BCQ35640274-A1FFA55B-A9B1-4D21-ACCB-21BE549BA5A3Q36365112-D71AF8CC-6691-4F04-9E46-9A5CE6876AA6Q36540907-946C9C89-DAD8-4210-A31F-468751EA7A7CQ37894564-9C3D7728-F54C-4889-84DF-AC2B8BF93B33Q38229870-B1FA9B61-A6CC-43AD-85F1-C2D30A85DE9AQ38407951-907EE748-A074-4A04-838E-0C2CC194108BQ38431852-9F0F59B0-1D66-4BEC-82C5-5A69CB941BE9Q38527037-09F7B720-E687-4446-96D7-6000646B1D5FQ38816375-20C61D99-2927-4063-9490-679AAB83EEBBQ39425453-A7D1D095-2FAB-481E-A5EE-88A6DAAFE294Q39695079-EBA1FD15-7F7F-4929-8EDB-3BDDD8A7CD34Q40077556-89D14466-08FA-4602-BDBC-916E6E636BDFQ40107337-09799851-7ED1-4E3B-BA0F-211995902F53Q41095390-97596E48-2F07-4584-BCCF-CEE9C2B38ED3Q41132442-4A2EFDF0-0C70-4425-8F66-8ECEACE8F45DQ41829954-76339C2D-E4FF-4764-92B4-19C964C3FFC7Q42370679-3624821C-03E3-4D3A-A03F-E7FA6393991EQ42786139-6C7389B0-143F-4637-9431-63B2FA22DBD5Q43053997-A316BC7D-1838-42D1-897E-B9FB6240A13CQ43510732-1865CF8F-214B-4D3B-A835-AB83A36A1E06Q43840390-D3B65333-89CB-4F89-8D9E-50B3C00B5037Q43857931-548B218D-B15A-44A4-8B59-94036693C2A1Q44190473-4B3990E5-8DF7-48FD-8BB0-5AB54D8B4CA9Q44273933-27C638A9-EDFD-4226-B743-A6CA7029AFEDQ44678169-BA254F3C-294F-4E31-970B-DE0E25CAD651Q44844669-E0E6C512-7E6E-4BDF-81F1-7190DEBCFED7Q46090346-0F0E5976-14B8-4240-9E8E-28CC247FFE40Q46463336-1A0202B6-E495-44AF-8AB7-5E13DE5F3897Q46604185-002FDF56-8B7E-43A5-99B2-EB5797532FF7Q46755077-6CA82BE6-680B-4F7D-B084-A2B91A462DFA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicolas Lamblin
@ast
Nicolas Lamblin
@en
Nicolas Lamblin
@es
Nicolas Lamblin
@nl
type
label
Nicolas Lamblin
@ast
Nicolas Lamblin
@en
Nicolas Lamblin
@es
Nicolas Lamblin
@nl
prefLabel
Nicolas Lamblin
@ast
Nicolas Lamblin
@en
Nicolas Lamblin
@es
Nicolas Lamblin
@nl
P106
P21
P31
P496
0000-0003-3754-1241